In a stunning twist that could alter the course of women's health rights in the United States, the Supreme Court is set to consider whether access to Mifepristone, a drug commonly used in both abortion and miscarriage care, should be restricted. This decision has the potential to affect women's access to this medication even in states where abortion is currently legal.
Mifepristone, which has been safely and effectively used for over 20 years, accounts for over half of all medication abortions across the country. Now, its future hangs in the balance, subject to a decision that could reverberate across the nation, impacting countless women in their childbearing years.
